Pantarol (Pantoprazole)

Pantoprazole, the active ingredient in Pantarol, is a proton pump inhibitor presented as an intravenous solution for intravenous use. It reduces gastric acid secretion and is employed in the management of acid‑related disorders such as gastro‑oesophageal reflux disease, peptic ulcer disease, and Zollinger‑Ellison syndrome.

GNH USA supplies Pantarol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The product meets EU quality standards and is available for global distribution.

Pantoprazole is indicated for several acid‑related conditions where suppression of gastric acid is required.

- Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining. - Erosive esophagitis: accelerates mucosal repair and reduces further injury. - Peptic ulcer disease: facilitates ulcer healing and prevents recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid production. - Prevention of NSAID‑induced gastric ulcers: reduces risk of ulcer formation in patients receiving non‑steroidal anti‑inflammatory drugs.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually self‑limiting. - Nausea or vomiting: transient gastrointestinal upset. - Abdominal pain: mild discomfort. - Flatulence: increased intestinal gas. - Dizziness: occasional light‑headedness.

Serious or Rare Side Effects: - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent diarrhoea with abdominal cramps. - Acute interstitial nephritis: signs of kidney inflammation such as reduced urine output. - Hepatic dysfunction: jaundice or abnormal liver enzymes. - Hypomagnesemia: muscle cramps, weakness, or irregular heartbeat. - Osteoporotic fractures: increased risk with long‑term use.

Before initiating therapy, consider the following safety measures.

- Assess renal function: adjust use in severe renal impairment. - Monitor magnesium levels: prolonged therapy may cause hypomagnesemia. - Evaluate for liver disease: use with caution in hepatic impairment. - Review concomitant medications: potential for drug‑drug interactions. - Pregnancy and lactation: category B, discuss risks and benefits with a healthcare professional. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Pantoprazole may interact with several drug classes; awareness helps avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Antiretrovirals (e.g., atazanavir, nelfinavir): decreased absorption and therapeutic effect. - Antifungal agents (e.g., ketoconazole, itraconazole): reduced bioavailability.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, monitor coagulation parameters. - Methotrexate: reduced clearance, watch for toxicity. - Digoxin: may increase serum levels, observe for signs of toxicity. - Clopidogrel: potential reduction in antiplatelet activity, assess clinical response.